ArticleNature communications2026
Efficient solution-processed light-emitting diodes based on organic-inorganic hybrid antimony halides.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isotropic-carrier-transport perovskite single crystal enables high-photoresponsivity solar-blind photodetectors for selective flame monitoring.Nature communications · 2026Article
- Coordination Compensation Stabilization of Monodentate-Ligand Copper-Iodide Hybrids for Efficient Light-Emitting Diodes With Record-High External Quantum Efficiency Above 20.Advanced materials (Deerfield Beach, Fla.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Organic-inorganic hybrid antimony halides are emerging emitters for solution-processed light-emitting diodes. However, achieving high-efficiency electroluminescence remains challenging resulting from the non-radiative recombination within emitters and inferior charge transport within device. Here, we develop an organic cation engineering to design a carbazole-functionalized triphenyl(9-ethyl-9H-carbazol-3-yl) phosphonium (TPPEtCz
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.